Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2013 2
2014 2
2015 1
2019 1
2020 3
2021 5
2022 4
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

15 results

Results by year

Filters applied: . Clear all
Page 1
Discovery and clinical translation of novel glaucoma biomarkers.
Beykin G, Norcia AM, Srinivasan VJ, Dubra A, Goldberg JL. Beykin G, et al. Prog Retin Eye Res. 2021 Jan;80:100875. doi: 10.1016/j.preteyeres.2020.100875. Epub 2020 Jul 10. Prog Retin Eye Res. 2021. PMID: 32659431 Free PMC article. Review.
Molecular Biomarkers for Glaucoma.
Beykin G, Goldberg JL. Beykin G, et al. Curr Ophthalmol Rep. 2019;7(3):171-176. doi: 10.1007/s40135-019-00213-0. Epub 2019 Jul 23. Curr Ophthalmol Rep. 2019. PMID: 33133776 Free PMC article.
Phase 1b Randomized Controlled Study of Short Course Topical Recombinant Human Nerve Growth Factor (rhNGF) for Neuroenhancement in Glaucoma: Safety, Tolerability, and Efficacy Measure Outcomes.
Beykin G, Stell L, Halim MS, Nuñez M, Popova L, Nguyen BT, Groth SL, Dennis A, Li Z, Atkins M, Khavari T, Wang SY, Chang R, Fisher AC, Sepah YJ, Goldberg JL. Beykin G, et al. Am J Ophthalmol. 2022 Feb;234:223-234. doi: 10.1016/j.ajo.2021.11.002. Epub 2021 Nov 13. Am J Ophthalmol. 2022. PMID: 34780798 Free PMC article. Clinical Trial.
Corrigendum to Phase 1b Randomized Controlled Study of Short Course Topical Recombinant Human Nerve Growth Factor (rhNGF) for Neuroenhancement in Glaucoma: Safety, Tolerability, and Efficacy Measure Outcomes. Am J Ophthalmol 2022;234:223-234.
Beykin G, Stell L, Halim MS, Nuñez M, Popova L, Nguyen BT, Groth SL, Dennis A, Li Z, Atkins M, Khavari T, Wang SY, Chang R, Fisher AC, Sepah YJ, Goldberg JL. Beykin G, et al. Am J Ophthalmol. 2022 Oct;242:254. doi: 10.1016/j.ajo.2022.07.018. Epub 2022 Aug 14. Am J Ophthalmol. 2022. PMID: 35977854 Free PMC article. No abstract available.
15 results